Peptilogics is a Pittsburgh-based company that aims to revolutionize the discovery process for novel peptide therapeutics, focusing on patients with serious and life-threatening diseases. By combining the untapped potential of peptide biology with the power of machine learning, Peptilogics utilizes precision engineering and design to create the next generation of medicines at a massive scale.
With their AI platform, Peptilogics is able to transform peptide drug discovery by leveraging advancements in AI algorithms, supercomputing, and peptide R&D. Their approach efficiently accesses new functional chemical space to design peptides with optimized properties for success as drug candidates, targeting serious conditions with high unmet medical needs and accelerating discovery efforts previously deemed impossible.
Generated from the website